We are live on ! Find out more
BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Est. Return 108.39%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+108.39%
3 Year Est. Return
+261.8%
5 Year Est. Return
+1,135.09%
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$10.6M
Cap. Flow
+$24.6M
Cap. Flow %
21.81%
Top 10 Hldgs %
74.15%
Holding
28
New
6
Increased
4
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$11.8M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$7.7M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$6.58M
4
TSRO
TESARO, Inc.
TSRO
+$3.34M
5
ONC
BeOne Medicines Ltd
ONC
+$2.25M

Top Sells

Rank Stock Value
1
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$9.21M
2
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
+$2.09M
3
ZGNX
Zogenix, Inc.
ZGNX
+$1.55M
4
SPHS
Sophiris Bio, Inc.
SPHS
+$786K
5
ACHV icon
Achieve Life Sciences
ACHV
+$60K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPXX
26
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
– –
-835,408
Closed -$9.21M
ZGNX
27
DELISTED
Zogenix, Inc.
ZGNX
– –
-168,000
Closed -$1.55M
SPHS
28
DELISTED
Sophiris Bio, Inc.
SPHS
– –
-546,088
Closed -$786K
1
2

Similar funds

FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
SEC
Seven Eight Capital New York $1.11B AUM 29.48% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Boxer Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Boxer Capital held 28 positions worth $113M, up 10% from $102M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Boxer Capital deployed $24.6M of net new capital in Q2 2016, opening 6 new positions and adding to 4 existing holdings. Its largest new stake was Acadia Healthcare: 200,938 shares worth $6.52M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 89% a quarter earlier.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $38K trimmed.

  • Boxer Capital's largest Q2 2016 buy was Acadia Healthcare: 200,938 shares worth $6.52M.
  • Boxer Capital added most to BeOne Medicines Ltd in Q2 2016, an estimated $2.25M increase.
  • Boxer Capital's biggest Q2 2016 reduction was Seagen Inc. Common Stock, cutting an estimated $38K.
  • Boxer Capital fully exited CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016, selling an estimated $9.21M.
  • Boxer Capital's ten largest holdings make up 74% of its $113M portfolio in Q2 2016.
  • Boxer Capital opened 6 new positions and closed 5 in Q2 2016.
  • Boxer Capital's portfolio value rose 10% quarter-over-quarter to $113M.

Based on Boxer Capital's 13F filing for Q2 2016, filed 15 Aug 2016.